New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 4, 2013
07:34 EDTZLCSZalicus says 'on track' to report two Z160 Phase 2 trials in Q4
The company said, "We remain on track to report top-line data for the two Phase 2 clinical trials of Z160, including lumbosacral radiculopathy and postherpetic neuralgia, in Q4. In addition, based on the positive results of the Z944 Phase 1b Laser-Evoked-Potentials study, we are planning to initiate a Phase 2 clinical study in an appropriate pain indication with a modified release formulation of Z944 next year.
News For ZLCS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ZLCS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use